#Global Interventional Cardiology Devices Market

[health-views-updates]

Global Doppler Ultrasound Industry Growth Analysis by Manufacturers, Regions, Type and Application, Forecast Analysis to 2032

The global Doppler ultrasound market is projected to experience steady growth over the next decade, with a compound annual growth rate (CAGR) of 3.77% from 2024 to 2032. Valued at USD 1.83 billion in 2023, the market is anticipated to reach USD 2.53 billion by 2032. This growth is driven by technological advancements in medical imaging, the rising prevalence of cardiovascular diseases, and the increasing demand for non-invasive diagnostic techniques.

Doppler ultrasound is a medical imaging technique that uses high-frequency sound waves to evaluate blood flow in blood vessels and organs. It is commonly used in cardiology, obstetrics, and vascular studies to detect blockages, abnormal blood flow, and other medical conditions, making it an essential tool in the healthcare industry.

Key Growth Drivers

Rising Incidence of Cardiovascular Diseases: Cardiovascular diseases, including hypertension, atherosclerosis, and heart disease, remain leading causes of mortality worldwide. Doppler ultrasound is a critical tool for diagnosing these conditions early by assessing blood flow and detecting abnormalities. The increasing prevalence of these diseases, particularly in aging populations, is expected to drive demand for Doppler ultrasound equipment.

Advancements in Doppler Technology: Technological advancements have enhanced the accuracy, efficiency, and portability of Doppler ultrasound devices. Innovations such as 3D and 4D Doppler ultrasound, as well as the integration of AI and machine learning into imaging systems, have improved diagnostic capabilities. These advancements allow for more precise assessments of blood flow, fetal monitoring, and the detection of vascular diseases, contributing to the market’s growth.

Rising Demand for Non-Invasive Diagnostic Techniques: As patients and healthcare providers increasingly prefer non-invasive and radiation-free diagnostic options, Doppler ultrasound stands out as a safe, efficient, and cost-effective tool. The non-invasive nature of Doppler ultrasound makes it ideal for monitoring a wide range of medical conditions without the need for surgical intervention or exposure to ionizing radiation.

Growing Use in Obstetrics and Gynecology: In obstetrics, Doppler ultrasound is extensively used to monitor fetal health by evaluating blood flow in the umbilical cord and fetal vessels. It helps detect issues such as fetal growth restrictions and placental insufficiency. As awareness of maternal and fetal health grows, the demand for Doppler ultrasound in prenatal care is expected to rise, further fueling market expansion.

Get Free Sample Report: https://www.snsinsider.com/sample-request/4499 

Challenges and Opportunities

While the Doppler ultrasound market shows promising growth, several challenges remain. One significant obstacle is the high cost of advanced Doppler systems, which may limit their adoption, particularly in emerging markets and smaller healthcare facilities. Additionally, the need for skilled technicians to operate these systems and interpret results may hinder widespread implementation in underdeveloped healthcare settings.

However, increasing government investments in healthcare infrastructure, especially in developing regions, and rising awareness of early diagnosis are creating new growth opportunities. Additionally, portable and handheld Doppler ultrasound devices are gaining popularity due to their ease of use and affordability, expanding the market to remote and rural areas where access to advanced diagnostic tools may be limited.

Regional Insights

North America currently dominates the Doppler ultrasound market, driven by a well-established healthcare infrastructure, a high prevalence of cardiovascular diseases, and the early adoption of advanced diagnostic technologies. Europe follows closely, with a growing focus on improving healthcare services and investments in medical imaging.

The Asia-Pacific region is expected to witness significant growth during the forecast period, driven by increasing healthcare spending, growing awareness of non-invasive diagnostic techniques, and a rise in cardiovascular diseases. Countries such as China, India, and Japan are at the forefront of this growth due to their large patient populations and expanding healthcare infrastructure.

Future Outlook

As the healthcare industry continues to evolve, the Doppler ultrasound market is set to experience steady growth. The increasing prevalence of chronic diseases, combined with the demand for non-invasive diagnostics and technological advancements, will drive the market forward. With a projected CAGR of 3.77% from 2024 to 2032, the Doppler ultrasound market is expected to reach USD 2.53 billion by 2032, cementing its role as a vital tool in modern healthcare diagnostics.

In conclusion, the global Doppler ultrasound market is on a path of sustainable growth, driven by innovation, rising healthcare needs, and expanding applications in various medical fields. From its current value of USD 1.83 billion in 2023, the market is poised to grow steadily over the next decade, offering enhanced diagnostic solutions for cardiovascular, obstetric, and vascular conditions.

Other Trending Reports

Functional Endoscopic Sinus Surgery Market

Artificial Intelligence in Healthcare Market

Radiotherapy Market

Nicotine Replacement Therapy Market

[tamanna31]

Coronary Stents Market Key Vendors, Manufacturers, Suppliers and Analysis Industry Report 2030

Coronary Stents Industry Overview

The global coronary stents market size was estimated at USD 9.32 billion in 2022 and is expected to grow a compound annual growth rate (CAGR) of 3.1% from 2023 to 2030.

Growing aging population and a rising prevalence of noncommunicable diseases such as cardiovascular diseases (CVDs), complex lesions, diabetes, obesity, and others are expected to drive demand for coronary stents over the forecast period. According to the World Health Organization (WHO), in 2019, CVDs were among the major causes of mortality worldwide of which ischemic heart disease (IHD) ranks as the most prevalent. In 2019, an estimated 17.9 million people died from CVDs, responsible for 32% of worldwide mortalities.

Gather more insights about the market drivers, restrains and growth of the Coronary Stents Market

According to research published by the National Library of Medicine in June 2021, one of the CVDs, coronary artery disease (CAD), causes roughly 6,10,000 fatalities yearly (an estimated 1 in 4 deaths) and is the major cause of mortality in the U.S. As a result, the unprecedented rise in CAD incidence is predicted to boost demand for an effective coronary stent device for treatment. This factor is expected to bolster the demand throughout the forecast period. Since a coronary stent is used in most of the Percutaneous Coronary Intervention (PCI) procedures.

The rising preference for minimally invasive surgeries (MIS) is another factor expected to boost the adoption of coronary stents over the forecast period. The advantages of these procedures include small incision wounds leading to higher patient satisfaction. These procedures also provide shorter hospital stays and facilitate quick recovery. Stenting technology is increasingly preferred over the conventional balloon angioplasty owing to the introduction of advanced DES and evolving bioresorbable scaffolds. Technological advancements in coronary stents, such as the development of bifurcated stents and the use of biodegradable materials, have led to efficient and improved outcomes of CVD treatment. Companies are proactively involved in product developments and partnerships and strategic collaborations. The aforementioned factors are expected to propel market growth over the forecast period.

The impact of COVID-19 on the market for coronary stents closely tracked the impact of COVID-19 on overall PCI procedures. During the pandemic's initial outbreak and periods of high local COVID-19 case counts, several states, towns, and nations issued orders to citizens to shelter in place or minimize the potential exposure to and transmission of illness, resulting in elective surgeries being postponed. As a result, total PCI procedure volumes-and hence coronary stent unit sales and revenues-went significantly lower in 2020. These revenues are expected to rise as facility capacity usage improves and resumes all the semi-elective to non-urgent procedures.

The notable competitors in the market for coronary stents announced revenue falls in their interventional cardiology portfolios, which include coronary stent devices, in 2020, due to the impact of the COVID-19 pandemic. Boston Scientific, for instance, reported a significant decrease in annual revenues in its Interventional Cardiology segment, which includes coronary stent devices, in 2020, but the company performed relatively well in the first quarter of 2021, reporting revenue growth of approximately 7% globally compared to the first quarter of 2020. In contrast, Abbott Laboratories Laboratories was the least affected, with less impact on its entire vascular segment in 2020, which includes coronary stent devices, in its 2020 annual results.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global disposable hospital gowns market size was valued at USD 3.68 billion in 2023 and is projected to grow at a CAGR of 12.9% from 2024 to 2030.

• The global knee braces market size was valued at USD 1.12 billion in 2023 and is projected to grow at a CAGR of 7.7% from 2024 to 2030.

Competitive Insights

Product launches, approvals, strategic acquisitions, and innovations are some of the crucial business strategies adopted by market participants to maintain and grow their global reach. Abbott Laboratories, Boston Scientific, and Medtronic accounted for a significant presence in the overall market. These companies have gained a notable presence in the market due to good strong performances in the lucrative DES market and large product portfolios spanning numerous different IC device categories. For instance, in August 2022, Medtronic launched the Onyx Frontier drug-eluting stent (DES). The new product offers advanced delivery management and improves the overall performance in the most challenging cases.

Despite the dominance of the three major manufacturers, the market for coronary stents is a blend of numerous global and local players. BIOTRONIK, for instance, has been able to establish a significant presence in the entire market by offering low pricing and new technologies that address unmet needs. Positive clinical results from BIOTRONIK's BIONYX, BIOFLOW-V, and BIOSOLVE trials, in conjunction with the use of BIOTRONIK's Orsiro DES and Magmaris BRS, have positioned the company well to compete against the market's largest players. BIOTRONIK is also one of the most competitive players in the overall BRS device market. Terumo Corporation, Biosensors International, and Cardinal Health are a few additional significant competitors in this market. Some of the prominent players in the global coronary stents market include:

Abbott

Medtronic

Boston Scientific Corporation

Terumo Corporation

B Braun Melsungen AG

Biotronik

Stentys SA

MicroPort Scientific Corporation

C. R. Bard, Inc.

Cook Medical

Order a free sample PDF of the Coronary Stents Market Intelligence Study, published by Grand View Research.

[adityarana1687-blog]

Coronary Stents Market Size To Reach $12.10 Billion By 2030

The global coronary stents market size is expected to reach USD 12.10 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.1% from 2023 to 2030. Increasing adoption of minimally invasive surgeries and Percutaneous Coronary Intervention (PCI) procedures is expected to drive the market in the coming years. For instance, according to The Korean Journal of Thoracic and Cardiovascular Surgery, the proportion of PCI for Coronary Artery Disease (CAD) was 78% in 2016, and the country-specific PCI proportion was 96%, which was significantly higher than the global average. As a result, the unprecedented growth in CAD incidence, along with an increase in the proportion of PCIs done in these CAD patients, is expected to raise demand for an effective coronary stent technology. 

Technological advancement and the launch of 2nd generation drug-eluting stents are further fueling the growth. For instance, Abbott Laboratories Laboratories' XIENCE Sierra became the first DES approved for CTO indications in the US in May 2018. Medtronic followed suit in early 2019, obtaining FDA approval for the use of its Resolute range of DES in CTO indications. In addition, many companies have recently launched newer versions of their coronary stent systems in the US, notably Boston Scientific's Synergy Megatron in January 2021 and Abbott Laboratories Laboratories' XIENCE Skypoint in June 2021. 

The global COVID-19 pandemic has had a negative impact on the market for coronary stents. According to guidelines from physician societies throughout the world, procedure deferrals primarily impacted less urgent or elective procedures for eligible patients. ACC's ((American College of Cardiology) 2020 guidance, for instance, recommended postponing non-urgent procedures like CTO interventions and surveillance angiography during the peak of the COVID-19 pandemic. These guidelines have influenced physicians' treatment decisions throughout the world. Additionally, according to the European Society of Cardiology recommendations, all emergency and urgent PCI procedures (treatment of STEMI, high or intermediate risk NSTEMI, cardiogenic shock, and unstable angina) should be continued during the peak of the pandemic and in the subsequent resurgence of COVID-19, while only elective PCI procedures (CTO interventions or treatment of NYHA II symptoms) should be deferred.

Moreover, recovery of the coronary stent market from the COVID-19 pandemic is anticipated to be aided by the continuous performance of urgent PCI procedures and an increase in capacity utilization for performing non-elective procedures.

The coronary stent market is driven by reimbursement coverage provided by the general public Center for Medicare & Medicaid Services (CMS) and private payers. The coverage is availed under national coverage determination for carotid artery stenting, including products and service providers. From January 2020, the Centers for Medicare & Medicaid Services (CMS) proposed reimbursement for some angioplasty and stenting procedures performed in the ambulatory surgical centers (ASC), which is expected to boost the market revenue over the forecast period. 

Request a free sample copy or view the report summary: Coronary Stents Market Report

Coronary Stents Market Report Highlights

Overall PCI procedure volumes treated with coronary stent devices will rise as the aging population and the PCI-eligible patient population grows, owing to new technologies and increased ability to treat severe lesions

The bioresorbable vascular scaffold segment is expected to be the second fastest growing segment due to its several advantages in treating coronary artery disease including temporary placement in the patient heart, ease for future treatments as it degrades over 3 years, and it dissolve completely in the patient body.

Favorable clinical trials have demonstrated that DES is better than standard BMS. As a result, in 2021, DES has dominated the market

North America dominated the coronary stents market and accounted for the largest revenue share of 32.6% in 2022 and is anticipated to witness the same trend over the foreseeable future.

The Asia Pacific market for coronary stents is expected to exhibit the fastest growth rate in terms of revenue generation. This market is driven by some additional variables of enhanced screening for CAD, economic growth, regulatory updates, and notable beneficial reimbursement in some countries such as Australia and South Korea.

Coronary Stents Market Segmentation

Grand View Research has segmented the global coronary stents market based on product, and region:

Coronary Stents Product Outlook (Revenue, USD Million, 2018 - 2030)

Bare Metal Stents (BMS)

Drug-Eluting Stents (DES)

Biodegradable

Non-Biodegradable

Bioresorbable Vascular Scaffold

Coronary Stents Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Europe

UK

Germany

France

Italy

Spain

Sweden

Norway

Denmark

Asia Pacific

Japan

China

India

Australia

Thailand

South Korea

Latin America

Brazil

Mexico

Argentina

Middle East and Africa

Saudi Arabia

South Africa

UAE

Kuwait

List of Key Players of Coronary Stents Market

Abbott

Medtronic

Boston Scientific Corporation

Terumo Corporation

B Braun Melsungen AG

Biotronik

Stentys SA

MicroPort Scientific Corporation

C. R. Bard, Inc.

Cook Medical

[b2bbusiness]

Contrast Media Injectors Market: A Comprehensive Overview

The global contrast media injectors market has been experiencing significant growth over the past few years, driven by the rising prevalence of chronic diseases, advancements in imaging technologies, and the increasing adoption of minimally invasive diagnostic procedures. Contrast media injectors are crucial medical devices used to enhance the quality of images obtained during diagnostic imaging procedures such as MRI, CT scans, and angiography. These devices inject contrast media into the body, which helps highlight specific areas of interest, providing clearer and more detailed images for accurate diagnosis.

Market Dynamics

1. Increasing Prevalence of Chronic Diseases: One of the primary drivers of the contrast media injectors market is the rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders. These conditions often require advanced imaging techniques for accurate diagnosis and treatment planning. As the global population ages, the incidence of these diseases is expected to increase, leading to a higher demand for diagnostic imaging procedures and, consequently, contrast media injectors.

2. Technological Advancements in Imaging Systems: Technological advancements in imaging systems have significantly improved the accuracy and efficiency of diagnostic procedures. Modern imaging techniques, such as MRI and CT scans, require high-quality contrast media injectors to deliver precise amounts of contrast agents. Innovations in injector technology, including automated and programmable injectors, have enhanced the safety and efficacy of these procedures, further boosting the market.

3. Growing Demand for Minimally Invasive Procedures: The trend towards minimally invasive diagnostic and therapeutic procedures is another key factor driving the market. Minimally invasive techniques are preferred by both patients and healthcare providers due to their reduced recovery times, lower risk of complications, and cost-effectiveness. Contrast media injectors play a crucial role in these procedures by providing real-time imaging, which aids in accurate diagnosis and treatment.

4. Rising Healthcare Expenditure: Increasing healthcare expenditure, particularly in developing economies, is contributing to the growth of the contrast media injectors market. Governments and private healthcare organizations are investing in advanced diagnostic equipment and technologies to improve patient care and outcomes. This investment is expected to drive the demand for contrast media injectors in hospitals, diagnostic centers, and clinics.

Market Segmentation

The contrast media injectors market can be segmented based on product type, application, end-user, and region.

1. By Product Type:

CT Injectors: These injectors are specifically designed for use in computed tomography (CT) procedures. They are the most widely used type of contrast media injectors due to the high volume of CT scans performed globally.

MRI Injectors: Used in magnetic resonance imaging (MRI) procedures, MRI injectors deliver contrast agents that enhance the quality of soft tissue images.

Angiography Injectors: These injectors are utilized in angiographic procedures to visualize blood vessels and diagnose cardiovascular conditions.

2. By Application:

Radiology: The largest segment, driven by the widespread use of diagnostic imaging procedures.

Interventional Cardiology: Increasing prevalence of cardiovascular diseases is boosting the demand for contrast media injectors in this segment.

Interventional Radiology: Used for a variety of minimally invasive procedures that require real-time imaging.

3. By End-User:

Hospitals: Hospitals are the primary users of contrast media injectors due to the high volume of imaging procedures performed.

Diagnostic Centers: These facilities are increasingly adopting advanced imaging equipment, including contrast media injectors, to enhance diagnostic accuracy.

Ambulatory Surgical Centers: The demand for contrast media injectors is growing in these centers due to the rising trend of outpatient diagnostic procedures.

4. By Region:

North America: The largest market due to the high adoption of advanced imaging technologies and the presence of key market players.

Europe: Growth is driven by increasing healthcare expenditure and the rising prevalence of chronic diseases.

Asia-Pacific: Expected to experience the fastest growth due to the rising demand for healthcare services, improving healthcare infrastructure, and increasing awareness about early disease diagnosis.

Latin America and Middle East & Africa: These regions are witnessing steady growth, supported by improving healthcare facilities and increasing investment in diagnostic technologies.

Buy the Full Report for More Insights on the Contrast Media Injectors Market Forecast Download a Free Sample Report

[credenceresearchdotblog]

The global electrophysiology devices market has witnessed steady growth in recent years and is expected to continue growing at a CAGR of 11.5% between 2023 and 2030. The market was valued at USD 6.3 billion in 2022 and is expected to reach USD 13.5 billion in 2030.The global electrophysiology devices market has seen significant growth in recent years, driven by advances in medical technology, a rising prevalence of cardiovascular diseases, and an increasing awareness of the benefits of early diagnosis and treatment of heart conditions. Electrophysiology, the study of the electrical properties of biological cells and tissues, is particularly crucial in the diagnosis and treatment of heart rhythm disorders. Electrophysiology devices are used to assess the electrical activity of the heart and treat arrhythmias, making them indispensable in modern cardiology.

Browse the full report at https://www.credenceresearch.com/report/electrophysiology-devices-market

Market Overview

The electrophysiology devices market encompasses a range of products, including electrophysiology catheters, ablation catheters, diagnostic catheters, mapping systems, and more. These devices are primarily used in procedures such as radiofrequency ablation, cryoablation, and cardiac resynchronization therapy, among others. The market has been growing steadily, with a compound annual growth rate (CAGR) of approximately 10% expected from 2023 to 2030.

Key Drivers of Market Growth

1. Increasing Prevalence of Cardiovascular Diseases: Cardiovascular diseases, particularly arrhythmias like atrial fibrillation, are on the rise globally. Factors such as aging populations, unhealthy lifestyles, and the increasing incidence of diabetes and hypertension contribute to this trend. The demand for electrophysiology procedures and devices has surged as more patients require accurate diagnosis and effective treatment for these conditions.

2. Technological Advancements: Technological innovations have significantly enhanced the capabilities of electrophysiology devices. Advanced mapping systems now allow for precise localization of abnormal electrical pathways in the heart, enabling targeted treatments with minimal risk. Additionally, the development of more efficient and safer ablation catheters has improved patient outcomes and expanded the scope of electrophysiology interventions.

3. Growing Awareness and Diagnosis Rates: Awareness of heart rhythm disorders and their potential consequences has been rising, leading to increased screening and early diagnosis. This trend is particularly noticeable in developed regions, where healthcare systems are well-equipped to offer advanced diagnostic procedures. The growing recognition of the importance of early intervention in managing arrhythmias has driven the demand for electrophysiology devices.

4. Supportive Government Policies and Funding: In several countries, governments have implemented policies to improve cardiovascular health, including funding for advanced medical equipment and research. For instance, the U.S. FDA has been proactive in approving new electrophysiology devices, encouraging innovation and ensuring that patients have access to the latest treatments.

Challenges Facing the Market

Despite the positive outlook, the electrophysiology devices market faces several challenges.

1. High Costs of Devices and Procedures: The cost of electrophysiology devices and the associated procedures can be prohibitively high, particularly in low- and middle-income countries. This limits access to these life-saving treatments for a significant portion of the global population.

2. Complexity of Procedures: Electrophysiology procedures require specialized skills and extensive training. The shortage of trained electrophysiologists in many regions poses a barrier to the widespread adoption of these devices, particularly in emerging markets.

3. Regulatory Hurdles: While regulatory bodies are generally supportive of innovations in electrophysiology, navigating the complex approval processes can be time-consuming and costly for manufacturers. Stringent regulatory requirements can delay the introduction of new products to the market, impacting the overall growth.

Regional Insights

North America currently dominates the electrophysiology devices market, thanks to its well-established healthcare infrastructure, high prevalence of cardiovascular diseases, and robust R&D activities. Europe follows closely, with significant contributions from countries like Germany and the U.K.

Asia-Pacific is expected to witness the fastest growth in the coming years, driven by increasing healthcare investments, a growing patient population, and rising awareness of cardiovascular health. China, Japan, and India are key markets in this region, offering significant growth opportunities for industry players.

Future Prospects

The future of the electrophysiology devices market looks promising, with ongoing innovations and increasing demand for advanced cardiovascular care. The integration of artificial intelligence and machine learning in electrophysiology is expected to further enhance diagnostic accuracy and treatment outcomes. Additionally, the development of miniaturized and wearable electrophysiology devices could revolutionize the market by enabling continuous monitoring and remote management of heart conditions.

Key Players

Abbott (U.S.)

Medtronic (Ireland)

Boston Scientific Corporation (U.S.)

Johnson & Johnson Services Inc (U.S.)

Stereotaxis Inc (U.S.)

AtriCure Inc (U.S.)

AngioDynamics (U.S.)

Biotronik Inc (Germany)

Segmentation

By Type

Ablation Catheters

Diagnostic Catheters

Mapping System

Accessories

Others

By Application

Atrial Fibrillation

Supraventricular Tachycardia (SVT)

Ventricular Tachycardia

Others

By End User

Hospitals & ASCs

Specialty Clinics & Diagnostic Centers

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

France

The U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/electrophysiology-devices-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[themarketupdate]

Cardiac Arrhythmia Monitoring Devices Market is set for a Potential Growth Worldwide: Excellent Technology Trends with Business Analysis

Most heart conditions require continuous heart monitoring. One of the most important factors contributing significantly to the growth of the global cardiac arrhythmia monitoring device market is the increase in the incidence of cardiovascular disease. According to a study by the World Health Organization (WHO), CVD is the leading cause of death worldwide and kills around 17.9 million people every year. And it's worth noting that of all deaths caused by a heart attack, four out of five are in the CVD category. Although arrhythmias cannot be completely cured, the best way to continuously monitor arrhythmia patients is to remotely monitor the patient using the arrhythmia monitoring equipment known as telecardiology. Telecardiology generally provides a monitoring device that can be attached to the chest area of patients with arrhythmias. Telecardiology is an inexpensive intervention for the elderly with heart failure. These devices monitor the heart's rhythm and record abnormalities in heart function. Most of these devices can be monitored remotely, which makes it possible to effectively and efficiently monitor patients with arrhythmias. As these devices improve patient comfort, telecardiology is becoming increasingly popular with both patients and doctors compared to regular patient visits to hospitals. The early application of telecardiology includes the transmission of ECGs by fax and advice from specialists over the phone. Recently, the use of telecardiology has changed in areas such as remote patient monitoring, EKG, echocardiograms, teleconsultation through video, surveillance and rapid interpretation of cardiac diagnostic tests, and conference calls for interventional cardiology.

Free Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/sample-report/12369-global-cardiac-arrhythmia-monitoring-devices-market?utm_source=Organic&utm_medium=Vinay

Latest released the research study on Global Cardiac Arrhythmia Monitoring Devices Market, offers a detailed overview of the factors influencing the global business scope. Cardiac Arrhythmia Monitoring Devices Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Cardiac Arrhythmia Monitoring Devices The study covers emerging player’s data, including: competitive landscape, sales, revenue and global market share of top manufacturers are Medtronic (Ireland), Boston Scientific (United States), Abbott Laboratories (United States), GE Healthcare (United States), BIOTRONIK (Germany), Koninklijke Philips (Netherlands), Asahi Kasei Corporation (Japan), MicroPort Scientific Corporation (China), Biotronik (Germany), Hill-Rom Holdings (United States), Nihon Kohden (Japan), BioTelemetry (United States), BPL Medical Technologies (India), ACS Diagnostics (United States), Shenzhen Mindray Bio-Medical Electronics (China), Lepu Medical Technology (China)

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Southeast Asia.

Contact Us:

Craig Francis (PR & Marketing Manager)

AMA Research & Media LLP

Unit No. 429, Parsonage Road Edison, NJ

New Jersey USA – 08837

sales@advancemarketanalytics.com

[lifesciencemarketresearch]

South Korea and Interventional Cardiology: Regional Procedure Volumes and Innovations in Medical Technology

Of the Asian geographies regarded as prominent global marketplaces for emerging medical technology, South Korea continues to establish itself as a leader across many procedural areas and market sub-segments. With the excitement created by Johnson & Johnson’s acquisition of Shockwave Medical, LSI’s medtech market research team conducted a deep-dive into the interventional cardiology procedure volumes in South Korea and the top medical device companies in the region. For more information visit https://www.slideshare.net/slideshow/south-korea-and-interventional-cardiology-regional-procedure-volumes-and-innovations-in-medical-technology/269965883

[health-views-updates]

Fluoroscopy Imaging Systems Market Insights: What to Expect in the Future

The global fluoroscopy imaging systems market is expected to witness steady growth over the next decade, with market value increasing from USD 1.99 billion in 2023 to USD 2.45 billion by 2032, registering a compound annual growth rate (CAGR) of 2.37% from 2024 to 2032. This growth reflects the rising demand for advanced imaging solutions across the healthcare sector, particularly in diagnostic and minimally invasive procedures.

Fluoroscopy is a real-time imaging technique that utilizes X-rays to provide dynamic visualizations of internal body structures. It is widely used in diagnostic procedures, interventional radiology, and image-guided surgeries. With continuous advancements in imaging technology, fluoroscopy imaging systems are becoming more sophisticated, enhancing the precision and safety of medical procedures.

Get Free Sample PDF: https://www.snsinsider.com/sample-request/4507 

Market Drivers

Growing Adoption of Minimally Invasive Surgeries: The increasing preference for minimally invasive surgeries (MIS) is a major driver of the fluoroscopy imaging systems market. MIS procedures, which involve smaller incisions, less pain, and faster recovery times, rely heavily on real-time imaging to guide surgical instruments with precision. Fluoroscopy provides the high-resolution, continuous imaging required for these procedures, making it an essential tool in fields such as orthopedics, cardiology, and gastroenterology.

Technological Advancements in Imaging: Advances in fluoroscopy technology, such as the development of digital fluoroscopy and mobile C-arms, are contributing to the market’s growth. Digital fluoroscopy systems offer enhanced image clarity, reduced radiation exposure, and improved workflow efficiency, making them highly sought after in hospitals and diagnostic centers. Additionally, mobile C-arms provide portability, enabling fluoroscopy imaging in various clinical settings, including operating rooms and emergency departments.

Aging Population and Rising Chronic Diseases: The global increase in the aging population and the growing prevalence of chronic diseases such as cardiovascular disorders, arthritis, and cancer are key factors boosting the demand for fluoroscopy imaging systems. These systems are vital for diagnosing and treating conditions that commonly affect older adults, including bone fractures, joint disorders, and vascular diseases. As the population ages, the need for advanced imaging techniques to manage these conditions will continue to rise.

Increased Focus on Patient Safety: With growing awareness of the risks associated with radiation exposure, there has been a shift toward safer imaging technologies. Modern fluoroscopy systems are equipped with dose-reduction features, minimizing radiation exposure to both patients and healthcare providers. This trend is expected to drive the adoption of newer, safer fluoroscopy imaging systems in medical facilities worldwide.

Challenges and Restraints

Despite the positive growth trajectory, several challenges may limit the market’s expansion. The high cost of fluoroscopy equipment and maintenance can be a barrier for smaller healthcare facilities, particularly in developing regions. Additionally, the availability of alternative imaging modalities, such as ultrasound and MRI, may pose competition to fluoroscopy in certain applications.

Furthermore, stringent regulatory requirements for the approval of medical imaging devices can slow the introduction of new systems into the market. Manufacturers must comply with rigorous safety and quality standards, which can delay product launches and add to development costs.

Regional Insights

North America currently leads the global fluoroscopy imaging systems market, driven by the high adoption of advanced imaging technologies, a well-established healthcare infrastructure, and the growing demand for minimally invasive procedures. Europe is also a key market, with a focus on enhancing healthcare services and increasing investments in diagnostic imaging.

The Asia-Pacific region is expected to experience significant growth over the forecast period, driven by the rising healthcare needs of a growing population, increasing investments in healthcare infrastructure, and the expanding prevalence of chronic diseases. Countries like China and India are witnessing rapid improvements in healthcare access, which will contribute to the demand for fluoroscopy systems.

Future Outlook

The fluoroscopy imaging systems market is poised for steady growth as the demand for advanced imaging solutions continues to rise. Technological innovations, coupled with the growing need for minimally invasive procedures and diagnostic accuracy, will drive the market forward. With a projected CAGR of 2.37%, the market is expected to reach USD 2.45 billion by 2032, offering opportunities for further advancements in imaging technology.

In conclusion, the fluoroscopy imaging systems market will continue to evolve, fueled by advancements in imaging technology, the aging population, and the increasing prevalence of chronic diseases. As healthcare systems worldwide focus on improving diagnostic and surgical outcomes, fluoroscopy imaging systems will remain a critical component of modern medical care.

Other Trending Reports

Process Analytical Technology Market

Biodegradable Medical Plastics Market

Smart Hospitality Market

IoT Medical Devices Market

[tamanna31]

 U.S. Patient Temperature Management Industry Size, Share & Review 2024-2030

U.S. Patient Temperature Management Market Size, Share & Trends Analysis Report By Type (Warming Systems, Cooling Systems), By Application (General Surgery, Cardiology), By End-use, And Segment Forecasts, 2024 - 2030

U.S. Patient Temperature Management Market

The U.S. patient temperature management market size was estimated at USD 1.30 billion in 2023 and is expected to exhibit a CAGR of 7.3% from 2024 to 2030. The market is substantially growing due to increased surgical procedures. This surge is attributed to several factors, including advancements in medical technology, an aging population, increasing number of hypothermia cases and an increasing prevalence of chronic diseases requiring surgical intervention. For instance, according to the Population Reference Bureau (PRB), the population of Americans aged 65 and above is expected to grow from 58 million (2022) to 82 million by 2050, marking a 47% increase. In addition, the proportion of this age group in the total population is projected to rise from 17% to 23%. Overall, the rise in the number of surgical procedures, coupled with the growing emphasis on patient safety and outcomes, is fueling the market growth.

Gather more insights about the market drivers, restrains and growth of the U.S. Patient Temperature Management Market

Patients undergoing cancer treatment, such as chemotherapy or radiation therapy, often experience fluctuations in body temperature as a result of treatment side effects, immune system suppression, or the cancer itself. According to the National Cancer Institute, hyperthermia, also known as thermal therapy or thermotherapy, is a treatment method that involves heating body tissues up to temperatures as high as 113 °F. This approach aims to damage and eliminate cancer cells while minimizing harm to healthy tissue. Effective temperature management is essential during cancer treatment to mitigate the risk of fever, hypothermia, or other temperature-related complications. For instance, according to the American Cancer Society (ACS) in January 2024, the anticipated number of new cancer cases in the U.S. is projected to surpass 2 million, translating to nearly 5,500 new cancer diagnoses each day.

Maintaining optimal body temperature is critical for successful outcomes in cardiac surgeries, catheterization procedures, and other cardiovascular interventions. According to data from the CDC, in 2022, approximately 20.1 million U.S. adults have coronary artery disease, and 805,000 Americans have a heart attack each year. The upward trend in these figures is linked to the growing prevalence of preventive cardiac surgeries conducted each year

Browse through Grand View Research's Medical Devices IndustryResearch Reports.

The global pediatric oral care market was estimated at USD 9.6 billion in 2023 and is projected to grow at a CAGR of 7.0% from 2024 to 2030.

The global pediatric wheelchair market size was estimated at USD 2.10 billion in 2023 and is projected to grow at a CAGR of 6.9% from 2024 to 2030. 

U.S. Patient Temperature Management Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. patient temperature management market report based on type, application, and end-use:

Type Outlook (Revenue, USD Million, 2018 - 2030)

Patient Warning Systems

Conventional Warning Systems

Blankets

Pads

Surface Warning Systems

Warming Systems

Blankets

Pads

Others

Open-basin

Fluid Warmers

Patient Cooling Systems

Conventional Cooling Systems

Blankets

Pads

Surface Cooling Systems

Cooling Systems

Blankets

Pads

Others

Dual Technology

Surface Warming Systems

Intravascular Warming Systems

Consumables

Irrigation Drapes

Fluid Warmer Drapes

Scope Warmer Drapes

Application Outlook (Revenue, USD Million, 2018 - 2030)

General Surgery

Cardiology

Pediatrics

Neurology

Orthopedic Surgery

Thoracic Surgery

Others

End-use Outlook (Revenue, USD Million, 2018 - 2030)

Operating rooms

Neonatal ICU

ICUs

Emergency room

Preoperative Care Units

Postoperative Care Units

Acute Care

Burn Centers

Cath Labs

Neurological Care Units

Others

Key U.S. Patient Temperature Management Companies:

Stryker Corporation

Zoll Medical Corporation

Medtronic

Bard Medical

3M Company

Pintler Medical

ECOLAB INC.

Currie Medical, Inc.

Belmont Medical Technologies

Cincinnati Sub-Zero Products, LLC

Recent Developments

In January, 2024, SourceMark announced a partnership with Gentherm Medical, a well-known manufacturer of systems for controlling patient temperature. Building on their previous collaboration, SourceMark is now the U.S. distributor for a few Gentherm patient warming product lines. traditional Arrow Midline, both of which come in single & double lumen options.

In June, 2023, Drägerwerk AG & Co. KGaA introduced the FDA-cleared Babyroo TN300, an open warmer providing supportive lung protection and temperature stability. It facilitates clinician access to routine care, emergencies, and procedures during the baby’s hospital stay while promoting family-centered care for healthy outcomes.

In July, 2024, Gentherm acquired Jiangmen Dacheng Medical Equipment Co., Ltd., which produced patient temperature control systems and other medical supplies & equipment.

Order a free sample PDF of the U.S. Patient Temperature Management Market Intelligence Study, published by Grand View Research.

[gqresearch24]

Absorbable Heart Stent Market Dynamics: Technological Advancements and Consumer Preferences | GQ Research

The Absorbable Heart Stent market is set to witness remarkable growth, as indicated by recent market analysis conducted by GQ Research. In 2023, the global Absorbable Heart Stent market showcased a significant presence, boasting a valuation of US$ 2.78 billion. This underscores the substantial demand for Absorbable Heart Stent technology and its widespread adoption across various industries.

Get Sample of this Report at https://gqresearch.com/request-sample/global-absorbable-heart-stent-market/

Projected Growth: Projections suggest that the Absorbable Heart Stent market will continue its upward trajectory, with a projected value of US$ 4.6 Billion by 2030. This growth is expected to be driven by technological advancements, increasing consumer demand, and expanding application areas.

Compound Annual Growth Rate (CAGR): The forecast period anticipates a Compound Annual Growth Rate (CAGR) of 7%., reflecting a steady and robust growth rate for the Absorbable Heart Stent market over the coming years.

Technology Adoption:

The absorbable heart stent market has witnessed a gradual but steady adoption rate since its inception. Initially, there were reservations regarding the efficacy and safety of absorbable stents compared to traditional metal stents. However, as clinical trials demonstrated comparable outcomes and advantages such as reduced risk of long-term complications, adoption rates have increased. Healthcare providers are increasingly embracing absorbable stents due to their potential to mitigate issues associated with permanent implants, such as late thrombosis and interference with future interventions.

Application Diversity:

The diversity in applications of absorbable heart stents is expanding, driven by advancements in materials science and medical technology. Initially developed for coronary artery disease, absorbable stents are now being explored for peripheral vascular interventions and structural heart procedures. Additionally, ongoing research is investigating their potential in pediatric cardiology and complex lesions. This diversification of applications underscores the versatility and adaptability of absorbable stent technology, opening up new avenues for patient care.

Consumer Preferences:

Consumer preferences in the absorbable heart stent market are evolving in tandem with increased awareness and education. Patients are becoming more proactive in their treatment decisions, seeking alternatives that offer improved safety profiles and reduced long-term risks. Consequently, there is a growing preference for absorbable stents among patients and healthcare professionals alike, especially in younger populations and those with concerns about the long-term effects of permanent implants. This shift in preferences is driving manufacturers to prioritize innovation and address consumer demands for safer and more effective treatment options.

Technological Advancements:

Technological advancements play a pivotal role in shaping the absorbable heart stent market landscape. Innovations in material science have led to the development of bioresorbable polymers with enhanced mechanical properties and biocompatibility. Furthermore, advances in imaging modalities and catheter-based delivery systems have improved procedural precision and patient outcomes. The integration of drug-eluting capabilities and bioactive coatings has also contributed to the refinement of absorbable stent technology, offering targeted therapy and reducing the risk of restenosis. Continuous research and development efforts are expected to drive further technological advancements, ushering in the next generation of absorbable heart stents.

Market Competition:

The absorbable heart stent market is characterized by intense competition among key players and emerging entrants. Established medical device companies are vying for market share through product differentiation, strategic partnerships, and acquisitions. Simultaneously, startups and research institutions are driving innovation with novel designs and manufacturing techniques. Regulatory approvals and clinical evidence play a crucial role in determining market competitiveness, with companies investing heavily in clinical trials and post-market surveillance to demonstrate the safety and efficacy of their products

Environmental Considerations:

Environmental considerations are increasingly influencing the absorbable heart stent market, reflecting broader trends towards sustainability and environmental responsibility in healthcare. The use of bioresorbable materials in stent manufacturing aligns with efforts to reduce the environmental impact of medical devices by minimizing the need for permanent implants and associated waste. Additionally, biodegradable polymers offer the potential for eco-friendly disposal post-procedure, reducing the burden on healthcare facilities and the environment.

Regional Dynamics: Different regions may exhibit varying growth rates and adoption patterns influenced by factors such as consumer preferences, technological infrastructure and regulatory frameworks.

Key players in the industry include:

Abbott Laboratories

Biotronik

Boston Scientific Corporation

Medtronic plc

Biotronik SE & Co. KG

Terumo Corporation

Meril Life Sciences Pvt. Ltd

Elixir Medical Corporation

The research report provides a comprehensive analysis of the Absorbable Heart Stent market, offering insights into current trends, market dynamics and future prospects. It explores key factors driving growth, challenges faced by the industry, and potential opportunities for market players.

For more information and to access a complimentary sample report, visit Link to Sample Report: https://gqresearch.com/request-sample/global-absorbable-heart-stent-market/

About GQ Research:

GQ Research is a company that is creating cutting edge, futuristic and informative reports in many different areas. Some of the most common areas where we generate reports are industry reports, country reports, company reports and everything in between.

Contact:

Jessica Joyal

+1 (614) 602 2897 | +919284395731

Website - https://gqresearch.com/

[divyabodhwani23]

Charting Progress: Insights into the Evolution of Precision Diagnostics

Minimally-Invasive Surgery Devices Market has revolutionized the field of medicine, offering patients less traumatic alternatives to traditional open surgeries. As technology continues to advance, the demand for minimally-invasive surgery devices is on the rise. These devices encompass a wide range of instruments, tools, and equipment designed to facilitate surgical procedures with minimal tissue damage and shorter recovery times. From laparoscopic instruments to robotic-assisted surgical systems, the market for minimally-invasive surgery devices is dynamic and rapidly evolving.

𝐆𝐞𝐭 𝐟𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞: https://www.marketdigits.com/request/sample/4666

One of the key drivers of the minimally-invasive surgery devices market is the increasing preference for less invasive surgical techniques among patients and healthcare providers. Compared to traditional open surgeries, minimally-invasive procedures offer several advantages, including reduced postoperative pain, shorter hospital stays, and faster recovery times. This has led to a growing demand for minimally-invasive surgery devices across various surgical specialties, including gynecology, urology, orthopedics, and cardiology.

The Minimally-Invasive Surgery Devices Market is valued at USD 24.7 billion in 2022 and is projected to reach USD 40.7 billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 7.65% during the forecast period spanning 2024-2032.

In recent years, technological advancements have played a significant role in driving innovation in minimally-invasive surgery devices. For example, the introduction of robotic-assisted surgical systems has enabled surgeons to perform complex procedures with enhanced precision and control. These systems combine cutting-edge robotics, imaging, and computer-assisted technologies to improve surgical outcomes and patient safety. Similarly, advancements in imaging technologies, such as high-definition cameras and 3D visualization systems, have provided surgeons with better visualization during minimally-invasive procedures, allowing for more accurate surgical maneuvers.

Major vendors in the global Minimally-Invasive Surgery Devices market: Abbott., EndoMed Systems GmbH, GE HealthCare, Intuitive Surgical, Medical Devices Business Services, Inc., Nuvasive, Inc., Strauss Surgical., Symmetry Surgical Inc., Siemens Healthcare Private Limited, TROKAMED GmbH, Zimmer Biomet, and Others.

Another factor contributing to the growth of the minimally-invasive surgery devices market is the increasing prevalence of chronic diseases and age-related conditions. Conditions such as cardiovascular disease, cancer, and obesity often require surgical intervention, and minimally-invasive approaches offer a less traumatic option for patients who may be at higher risk for complications from traditional open surgeries. As the global population continues to age and the prevalence of chronic diseases rises, the demand for minimally-invasive surgery devices is expected to increase accordingly.

Additionally, regulatory agencies and healthcare organizations are increasingly recognizing the benefits of minimally-invasive surgery in terms of patient outcomes and healthcare costs. As a result, there has been a push to incentivize the adoption of minimally-invasive techniques and technologies through reimbursement policies and quality improvement initiatives. This has created a favorable environment for manufacturers of minimally-invasive surgery devices, as healthcare providers seek to invest in technologies that can improve patient care while reducing overall healthcare expenditures.

However, despite the numerous advantages of minimally-invasive surgery devices, there are also challenges and limitations to consider. For example, the initial capital investment required to purchase robotic-assisted surgical systems can be significant, making it inaccessible to some healthcare facilities, particularly in resource-constrained settings. Additionally, there may be a learning curve associated with adopting new technologies, and surgeons may require specialized training to effectively utilize minimally-invasive surgery devices.

Furthermore, while minimally-invasive procedures generally result in shorter hospital stays and faster recovery times, they may not be suitable for all patients or all surgical indications. In some cases, open surgery may still be necessary to achieve optimal outcomes, particularly for complex or emergent procedures. Therefore, it is essential for healthcare providers to carefully evaluate each patient's individual needs and medical history when determining the most appropriate surgical approach.

In conclusion, the minimally-invasive surgery devices market is poised for continued growth and innovation as technological advancements drive the development of new and improved surgical techniques and technologies. With an aging population, increasing prevalence of chronic diseases, and growing emphasis on value-based healthcare, minimally-invasive surgery offers a promising solution for improving patient outcomes and reducing healthcare costs. By addressing challenges and leveraging opportunities, manufacturers of minimally-invasive surgery devices can play a key role in shaping the future of surgical care.

[credenceresearchdotblog]

The global fixed and mobile C-arms market value is estimated at USD 2,757.13 million in 2023 and is forecast to reach USD 4,352.08 million by 2032, exhibiting a compound annual growth rate (CAGR) of 5.87% during the 2023–2032 period.In the realm of medical imaging, C-arms play a pivotal role, offering dynamic imaging solutions for a range of diagnostic and therapeutic procedures. The fixed and mobile C-arms market is a crucial segment of the medical imaging industry, characterized by a range of applications in orthopedics, cardiology, and surgery. This article explores the current landscape, trends, challenges, and future outlook of the fixed and mobile C-arms market.

Browse the full report at https://www.credenceresearch.com/report/fixed-and-mobile-c-arms-market

Market Overview

Fixed C-arms are stationary imaging devices typically used in surgical environments. They provide high-quality imaging and are integral to procedures requiring constant imaging support, such as complex surgeries or interventional procedures. Mobile C-arms, on the other hand, are portable and can be moved around different locations within a healthcare facility. Their versatility makes them ideal for emergency rooms and operating theaters where space and imaging flexibility are crucial.

Market Trends

1. Technological Advancements: The fixed and mobile C-arms market is witnessing rapid technological advancements. Innovations include the development of digital C-arms with advanced image processing capabilities, integration of real-time 3D imaging, and enhanced fluoroscopic capabilities. These advancements improve image clarity, reduce radiation exposure, and enhance overall procedural outcomes.

2. Growing Demand for Minimally Invasive Procedures: There is a rising demand for minimally invasive surgeries (MIS) driven by the benefits of reduced recovery time and lower risk of complications. C-arms, particularly mobile units, are essential for guiding these procedures, leading to increased adoption in various healthcare settings.

3. Rising Geriatric Population: The global aging population is contributing to the growth of the C-arms market. As the elderly are more prone to conditions such as osteoporosis and cardiovascular diseases, the need for diagnostic and interventional procedures utilizing C-arms is increasing.

4. Healthcare Infrastructure Development: The expansion of healthcare infrastructure in emerging markets is boosting the demand for both fixed and mobile C-arms. Governments and private sectors are investing in modernizing healthcare facilities, which includes the acquisition of advanced imaging equipment.

Challenges

1. High Costs: The initial investment and maintenance costs of C-arms can be substantial. This can be a barrier for smaller healthcare facilities or those in developing regions. While the cost is justified by the benefits, financial constraints may limit access to the latest technologies.

2. Radiation Exposure Concerns: Despite technological improvements aimed at reducing radiation, concerns about radiation exposure for both patients and healthcare professionals persist. Ongoing efforts to develop safer imaging technologies are crucial to addressing these concerns.

3. Technological Complexity: As C-arm systems become more advanced, they also become more complex. This complexity can pose challenges in terms of training and maintenance, requiring healthcare facilities to invest in ongoing education and support.

4. Regulatory and Compliance Issues: Navigating the regulatory landscape for medical devices can be challenging. Compliance with standards and regulations is essential for market entry and maintaining product safety and efficacy.

Future Outlook

The fixed and mobile C-arms market is poised for growth, driven by continuous technological innovation and increasing healthcare demands. Key factors shaping the future include:

1. Integration with Advanced Technologies: Future C-arms are likely to incorporate artificial intelligence (AI) and machine learning to enhance image analysis and automate routine tasks. This integration will further improve accuracy and efficiency in diagnostics and procedures.

2. Expansion in Emerging Markets: The growth of healthcare infrastructure in emerging economies presents significant opportunities for market expansion. As these regions develop their healthcare capabilities, the demand for C-arms is expected to rise.

3. Focus on Patient Safety and Comfort: There will be a continued emphasis on reducing radiation exposure and improving patient comfort. Innovations in shielding technologies and advanced imaging techniques will play a crucial role in addressing these concerns.

4. Enhanced Portability and Versatility: The development of more compact and versatile mobile C-arms will likely meet the growing needs of various healthcare settings, including outpatient clinics and remote locations.

Top Key Players

GE Healthcare

Philips Healthcare

Siemens Healthineers

Canon Medical Systems

Ziehm Imaging

Hologic, Inc.

OrthoScan, Inc.

Shimadzu Corporation

Toshiba Medical Systems (now part of Canon)

Hitachi Medical Systems

Segmentations

By Product

Mobile C-Arms

Fixed C-Arms

By End User

Diagnostics Centers

Hospitals

Ambulatory Care Centers

Others

By Application

Neurosurgery

Cardiovascular

Orthopedics and Trauma

Pain Management

Gastroenterology

Others

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

France

The U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/fixed-and-mobile-c-arms-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com